Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020) : Statement of the Austrian Society of Pneumology (ASP)

Wien Klin Wochenschr. 2020 Jul;132(13-14):365-386. doi: 10.1007/s00508-020-01691-0.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic is currently a challenge worldwide. In Austria, a crisis within the healthcare system has so far been prevented. The treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV‑2 infections, should continue to be based on evidence-based CAP guidelines during the pandemic; however, COVID-19 specific adjustments are useful. The treatment of patients with chronic lung diseases has to be adapted during the pandemic but must still be guaranteed.

Keywords: ARDS; COVID-19; Chronic lung disease; Community acquired pneumonia; SARS-CoV‑2.

MeSH terms

  • Adolescent
  • Adult
  • Austria
  • Betacoronavirus
  • COVID-19
  • Child
  • Chronic Disease
  • Coronavirus Infections* / complications
  • Coronavirus Infections* / diagnosis
  • Coronavirus Infections* / therapy
  • Coronavirus*
  • Humans
  • Lung Diseases / complications*
  • Lung Diseases / therapy
  • Pandemics*
  • Pneumonia, Viral* / complications
  • Pneumonia, Viral* / diagnosis
  • Pneumonia, Viral* / therapy
  • Practice Guidelines as Topic
  • Pulmonary Medicine*
  • SARS-CoV-2